CONSUN PHARMAC.GR.HD -10 Asset Resilience Ratio

Latest as of December 2025: 41.64%

CONSUN PHARMAC.GR.HD -10 asset resilience ratio. CONSUN PHARMAC.GR.HD -10 (C1P) has an Asset Resilience Ratio of 41.64% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See C1P defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

€2.67 Billion

≈ $3.12 Billion USD Cash + Short-term Investments

Total Assets

€6.41 Billion

≈ $7.49 Billion USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of CONSUN PHARMAC.GR.HD -10 (2021–2025)

Asset resilience ratio of CONSUN PHARMAC.GR.HD -10 from 2021 to 2025. This chart shows how CONSUN PHARMAC.GR.HD -10's Asset Resilience Ratio has changed over time. Read C1P total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down CONSUN PHARMAC.GR.HD -10's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of CONSUN PHARMAC.GR.HD -10.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€2.67 Billion	41.64%
Total Liquid Assets	€2.67 Billion	41.64%

Asset Resilience Insights

Very High Liquidity: CONSUN PHARMAC.GR.HD -10 maintains exceptional liquid asset reserves at 41.64% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

CONSUN PHARMAC.GR.HD -10 Industry Peers by Asset Resilience Ratio

Compare CONSUN PHARMAC.GR.HD -10's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Viatris Inc NASDAQ:VTRS	Drug Manufacturers - Specialty & Generic	1.48%
Tianjin Zhongxin Pharmaceutical Group Corp Ltd SHG:600329	Drug Manufacturers - Specialty & Generic	5.92%
Walvax BioTech SHE:300142	Drug Manufacturers - Specialty & Generic	2.20%
Curaleaf Holdings Inc. TO:CURA	Drug Manufacturers - Specialty & Generic	3.73%
Tianjin Chase Sun Pharmaceutical Co Ltd SHE:300026	Drug Manufacturers - Specialty & Generic	-0.89%
Changzhou Qianhong Biopharma Co Ltd SHE:002550	Drug Manufacturers - Specialty & Generic	18.70%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Harbin Gloria Pharmaceuticals SHE:002437	Drug Manufacturers - Specialty & Generic	9.04%

CONSUN PHARMAC.GR.HD -10 Asset Resilience Ratio by Year (2021–2025)

CONSUN PHARMAC.GR.HD -10 asset resilience ratio by year from 2021 to 2025. The table below shows the annual Asset Resilience Ratio data for CONSUN PHARMAC.GR.HD -10.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	41.64%	€2.67 Billion ≈ $3.12 Billion	€6.41 Billion ≈ $7.49 Billion	+25.27pp
2024-12-31	16.37%	€958.00 Million ≈ $1.12 Billion	€5.85 Billion ≈ $6.84 Billion	+1.21pp
2023-12-31	15.16%	€834.94 Million ≈ $976.13 Million	€5.51 Billion ≈ $6.44 Billion	+3.12pp
2022-12-31	12.04%	€589.17 Million ≈ $688.80 Million	€4.89 Billion ≈ $5.72 Billion	+6.77pp
2021-12-31	5.27%	€230.00 Million ≈ $268.89 Million	€4.36 Billion ≈ $5.10 Billion	--

pp = percentage points

About CONSUN PHARMAC.GR.HD -10

F:C1P Germany Drug Manufacturers - Specialty & Generic

Market Cap

$1.64 Billion

€1.41 Billion EUR

Market Cap Rank

#7406 Global

#1040 in Germany

Share Price

€1.67

Change (1 day)

+0.00%

52-Week Range

€1.34 - €2.18

All Time High

€2.18